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Transpleural Lung Biopsy by the 
Thoracoscopic Route in Patients with Diffuse 
Interstitial Pulmonary Disease*
J. H. Dijkman, M.D.;° J. W. M. van der Meer, M.D .;f W. Bakker,
A. M. J. Wever, M.D.;° and P. ]. van der Broek, M .D .f
Thoracoscopy was carried out in 81 cases of diffuse 
pulm onary disease in order to obtain lung tissue for 
biopsy. A fter we established artificial pneum othorax, the 
thoracoscope was introduced under local anesthesia, m ul­
tiple biopsy specimens (0 3 mm) were obtained under 
visual control, and an underw ater sealed drain was left 
in place. The m ethod was used to determ ine the cause 
of x-ray shadowing and respiratory distress in 26 im ­
m unocom prom ised patients. W ithin 2-48 hours, all 
biopsy specimens provided sufficient niicrobiologic and 
morphologic inform ation to guide m anagem ent, *g> 
specific antim icrobial drugs, decreasing or intensifying
im m unosuppression, or cytostatic therapy. Thoracoscopy 
was tolerated better than fiberoptic bronchoscopy, espe­
cially in hypoxic patients. Persisting or recurring pneu- 
m othoraces were seen in four patients and was not a 
m ajor complication. In one very ill patient, the spleen 
was punctured accidentally before biopsy specimens 
were taken. Of 63 nonim m unocom prom ised patients, a 
histologic diagnosis was obtained in 57 (90 percent). In 
most of these patients, previous biopsy procedures had 
produced inconclusive results. Also in this group per­
sisting or recurring pneum othoraces were seen in four 
patients, but closed eventually in a conservative way.
T ?  requently confronted with immunocompromised 
patients who develop diffuse pulmonary infiltra­
tions and rapidly progressive respiratory distress, 
we were dissatisfied with the methods currently 
available to obtain a diagnosis solid enough to 
rely upon for management and therapeutic ap­
proach. In such patients, good microbiologie and 
morphologic information is badly needed to define 
the pathologic process, to estimate its reversibility, 
to choose between intensifying or reducing immuno­
suppressive therapy, and to identify possible op­
portunistic pathogens for selection of an appropri­
ate antimicrobial regimen.
Open chest surgery under general anesthesia is 
hazardous for many such patients since it often 
leads to prolonged artificial respiration connected 
with risks of multiple infections and the problem 
how to wean the patient from the ventilator. Trans- 
bronchial fiberoptic biopsy under local anesthesia 
may yield useful information in patients with diffuse 
interstitial pulmonary disease. Although the method 
is successful in 80 to 90 percent of cases of sarcoid-
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osis,1,2 it is less successful (40 percent) in fibrosing 
alveolitis,3 and in many other types of diffuse pul­
monary disease the specimens obtained are too 
small for adequate pathologic studies.4 In contrast 
to earlier reports,5-6 we found fiberoptic bronchos­
copy of poor diagnostic value in immunocom­
promised patients because of frequent oropharyn­
geal contamination of aspirates and insufficient 
amount of biopsied tissue for morphologic investiga­
tions. Transthoracic needle core and drill biopsies 
produce small specimens also, and their complica­
tion rate is rather high to balance the average yield .7
In our department, thoracoscopy ( pleuroscopy) 
under local anesthesia has been practiced for many 
years in patients with pneumothorax and pleural 
disease, and since 1975 we have extended the 
thoracoscopic approach to patients with diffuse pul­
monary disease to obtain biopsies of lung tissue.
M e t h o d s
About 30 minutes after premedication (usually with 
atropine 0.5 mg, droperidol 2.5 mg and fentanyl 0.05 mg in­
tramuscularly) the patient is brought into a horizontal lateral 
(right or left) position, with the head down to prevent pos­
sible air emboli reaching the brain (Fig 1A). Usually we 
choose the 4th or 5th intercostal space in the mid-axillary 
line for entrance. To obtain adequate local anesthesia, in­
filtration with 10 to 15 ml lidocaine 2 percent up to the 
pleura is sufficient. After having established an artificial 
pneumothorax (300 to 600 m l) by using a needle connected 
to a manometer, an incision of 1.5 to 2 cm is made. Sub-
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F i g u r e  1. Position of the patient and instruments used.
cutaneous tissues, including the parietal pleura, are bluntly 
dissected, and the thoracoscope (Storz, Tuttlingen, West 
Germany) is introduced via a trocar (0.9 nun). In this 
way, the lung surface can be inspected and multiple biopsies 
from the superficial lung tissue can be taken under visual 
control. The instruments used are shown in Figure IB. The 
forceps, in open position, is dipped into the pulmonary 
tissue (F ig 2 A ),  is closed and subsequently withdrawn (Fig 
2B). A piece of tissue with a diameter of approximately
3 mm is torn off when withdrawing the forceps from the 
pleural cavity into the trocar (Fig 2C). Biopsies can be 
taken from any site. Inspection thereafter shows a shallow 
lesion, which may bleed slightly. Abundant bleeding is not 
observed, because superficial lung tissue contains only capil­
lary vessels and the specimen is not cut away but torn off. 
Usually we take eight to ten biopsy specimens. A drain 
is left in the trocar and sealed under water. We never apply 
active suction by which air-flow tends to keep the holes 
open. We prefer fast closure of the lung over fast elimina­
tion of die pleural air.
After collection, the biopsy specimens are immediately 
sent to a number of laboratories (pathology, microbiology, 
parasitology, mycology) which are notified in advance to 
ensure optimal care for the material obtained.8
Macroscopic (Fig 3A) and microscopic views (Fig 3B) 
of a representative transpleural biopsy specimen (0.3 mm) 
show that the size of the sample is much larger than ob­
tained by transbronchial biopsy.
R e s u l t s
Thoracoscopic lung biopsy was performed in two 
categories of patients: immunocompromised indi­
viduals in whom a rapid diagnosis was mandatory, 
and in non-immunocompromised individuals being 
investigated for diffuse pulmonary disease of un­
known origin.
F i g u r e  2. Biopsy of lung tissue through the thoracoscope. For explanation see text.
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AImmunocompromised Patients
Biopsies were performed for 28 episodes of dif­
fuse pulmonary infiltration in 26 immunocompro­
mised patients, whose underlying diseases are listed 
in Table 1. Results of the biopsy procedure, clinical 
outcome and complications are presented in Table
2 .
In all eight patients who developed diffuse pul­
monary disease after renal transplantation, infec­
tions caused by opportunistic pathogens were dem­
onstrated. These findings resulted in reducing 
immunosuppressive treatment and, if available, insti­
tuting selective antimicrobial therapy, eg, cotri- 
moxazol in Pneumocystis or hyperimmune serum in 
life-threatening cytomegalovirus pneumonitis .9 All 
patients in this group with Pneumocystis or CMV- 
infection recovered. The patient with diffuse No- 
cardia pneumonitis died after ten days in spite of 
administration of several antimicrobial drugs.
Most of the patients with bone marrow graft for 
acute leukemia10 showed severe interstitial pneumo­
nitis with fibrosis,11 considered to be caused in part 
by previous irradiation and cytostatic drugs and in 
part resulting from a graft-vs-host reaction. This 
condition was lethal in four of the six patients de­
spite intensive immunosuppressive treatment. Au­
topsy was performed in three patients and yielded 
no other diagnosis than idiopathic interstitial fibro­
sis. In addition, the patient with extensive Asper- 
gillus-pneumonia after bone marrow transplantation 
also died.
In the other 13 patients, with various types of 
malignant or other diseases (Table 1), who were 
treated with cytostatic and immunosuppressive 
drugs, thoracoscopic lung biopsy revealed oppor-
Figure 3. Macroscopic view of biopsy 
specimens (0 3 m m ) and a microscopic 
picture carcinomatous lymphangitis (orig­
inal magnification 10 X 40).
tunistic infections in three, and interstitial pneum o­
nitis with fibrosis considered to be due to previous 
cytostatic drug therapy in three, radiation in one 
and of unknown cause in four. Two patients had 
pulmonary infiltrations of malignant origin. In the 
patients with fibrosis, it was considered important 
to exclude opportunistic infections, so that corti­
costeroid treatment could be given or intensified. 
Most of the patients in this group (8 of 13) sur­
vived the period of respiratory distress after appro­
priate therapy. In the patient with leukemic pulmo­
nary infiltration, the procedure was terminated 
because of splenic puncture (see below) before 
biopsies were taken. The diagnosis was obtained 
post mortem.
Thoracoscopic lung biopsy was performed twice 
in two patients, on different occasions. One patient 
had Pneumocxjstis carinii infection two months after 
renal transplantation and exhibited a cytomegalo­
virus infection six weeks later. The other patient had 
been treated with cyclophosphamide because of
T able  1— Underlying D isord er(s )  in 26  
Im m u n o c o m p ro m ise d  Patients
Renal transplantation 8
Bone marrow transplantation 7
Leukemia 3
Wegener’s granulomatosis 2
Hodgkin’s disease 2
Angioimmunoblastoma 2
Systemic lupus erythematosus 2
Breast carcinoma 1
Small-cell bronchial carcinoma 1
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T able 2— Results o f  28  Thoracoscopic Lung  Biopsies in 26  Im m u n o co m p ro m ised  Patients
Predisposing Factors 
and Diagnoses
No.
Cases
Negative 
Findings in 
Fiberoptic 
Biopsy *
Diagnosis
by
Thoraco­
scope
Confirma­
tion at 
Autopsy Recovery
Duration of 
Drainage, 
days 
(Mean and 
Range)
Complications 
(No. Patients)
Renal transplantation 8 8 7 2.8 (1-8)
Pneumocystis carinii 2 1 2
Cytomegalovirus 5 5 Pneumothorax (1 )
Nocardia 1 1 1
Bonemarrow transplantation 7 7 2 8.0 (3-28)
Interstitial pneumonitis 6 3 2 Pneumothorax (1 )
Aspergillus 1 1
Various diseases (Table 1) 13 12 8 3.5 (1-7)
treated with cytostatics,
immunosuppressive drugs
and radiation
Pneumocystis carinii 2 1
Cytomegalovirus 1 1
Interstitial pneumonitis Pneumothorax (1 )
due to:
methotrexate 1 1 1
busulfan 1 1 1
cyclophosphamide 1 1 1
radiation 1 1 1
unknown origin 4 1 2 Pneumothorax (1 )
Angio immunoblastic infiltration 1 1
Leukemic infiltration I t I t Splenic puncture (1 )
Total 28 8 27 6 17 4.4 (1-28) Pneumothorax (4)
Splenic puncture (1)
*A positive finding was never obtained.
fBiopsy not carried out because of splenic puncture.
W egener’s granulomatosis. First, he developed in­
terstitial fibrosis, diagnosed as an effect of the drug. 
He was successfully treated with corticosteroids. 
Three months later, pulmonary infiltration and 
respiratory distress recurred, and Pneumocystis 
carinii was found by biopsy.
Although most of these immunocompromised pa­
tients, especially the patients who had bone mar­
row or kidney grafts, showed intense x-ray film 
shadowing and suffered from respiratory distress 
which needed oxygen-supply, the artificial pneumo­
thorax and the thoracoscopy were well tolerated and 
caused less discomfort than was caused by tracheal 
anesthesia for previous fiberoptic bronchoscopy in 
several of them. Nearly all these patients received 
oxygen by nasal route or mask and thoracoscopy was 
usually performed without increasing the oxygen 
supply they had already. We had no opportunity 
to monitor blood gas levels during the procedure. 
However, heart rate and blood pressure were mon­
itored and showed no major changes.
While we have not considered hypoxia to be a 
contraindication for thoracoscopy, we always have 
refused hypercapnie patients. In spite of this policy, 
artificial respiration was needed in three patients
at 12 hours, two and five days after thoracoscopy. 
All died eventually. However, we strongly feel that 
progression of the respiratory distress was caused by 
the underlying pulmonary disease, rather than by 
the biopsy procedure.
Using an underwater-sealed chest drain without 
suction, re-expansion of the lung usually was com­
pleted within a few hours or days, after which the 
drain was clamped for another day and subsequent­
ly, after x-ray examination, removed. The duration 
of chest drainage was 1-21 (mean 4.4, median 3.0) 
days. In three patients, re-expansion of the lung took 
more than eight days and in two others, pneumo­
thorax recurred after removal of the drain. This 
complication only caused some discomfort in three 
patients, but to some extent hampered manage­
ment in two others, who went on artificial respira­
tion.
Many of the patients were thrombocytopenic and 
showed a bleeding tendency. In such cases platelet 
transfusions were given shortly before the proce­
dure. We have accepted a maximal bleeding time 
( Ivy12) of seven minutes. In no patient did lung 
biopsy cause more than superficial bleeding. How­
ever, in one patient puncture of the spleen occurred
CHEST /  82 /  1 /  JULY, 1982 79
accidentally which caused a peritoneal hemorrhage. 
This patient was so distressed that it was not pos­
sible for him to assume a strict horizontal position. 
In trying to establish artificial pneumothorax, the 
spleen was punctured, probably because the patient 
had a large leukemic spleen which pushed the 
diaphragm upwards. After this experience, we have 
not accepted any patients who were not able to 
lie down completely horizontally.
Most patients had granulocytopenia as well, but 
no infections occurred at the site of the biopsy or 
chest drain after the procedure.
In all 27 patients in whom lung tissue was ob­
tained, a diagnosis was available within 48 hours, 
in many of them even within two hours (by micro­
biologie studies and frozen tissue sections). Re­
ceiving treatment directly guided by the diagnosis,
17 survived the acute and critical period of severe 
respiratory disease. Most of the lethal cases were 
patients with progressive, diffuse interstitial pneu­
monitis and fibrosis, occurring two to four months 
after bone marrow transplantation and not re­
sponding to high doses of corticosteroids.
Nonimmunoco mprom isecl Patients
Along with growing experience in immunocom­
promised patients, the biopsy technique was applied
as a diagnostic procedure in diffuse pulmonary dis­
ease in other patients.
Results in a group of 63 non-immunocompromised 
patients, with diffuse interstitial pulmonary disease 
in which a diagnosis was desirable and other in­
vestigations, including fiberoptic bronchoscopy in 
33, had failed to yield a diagnosis, are given in 
Table 3. In some of these patients, especially those 
with pneumoconiosis, sarcoidosis and carcinomatous 
lymphangitis, the lung surface showed small irreg­
ularities which helped us choose the site of the 
biopsies. In 57 patients, thoracoscopic biopsy was 
sufficient to obtain a diagnosis. The procedure was 
considered to be nonconclusive in six patients, and 
was followed by open chest surgery in five of them. 
This added essential information in three patients, 
with W egener’s disease, pulmonary veno-occlusive 
disease, and tuberculosis, respectively. In two 
others, one patient with allergic alveolitis and one 
with histiocytosis X, the thoracoscopic biopsy proved 
to have been sufficient in retrospect, because open 
biopsy yielded the same information as was already 
obtained by thoracoscopy. One patient with incon­
clusive thoracoscopic biopsy was considered to 
have multiple pulmonary microemboli as indicated 
by serial scintigraphy, and further diagnostic meas­
ures were abandoned.
Thus, in more than 90 percent of our nonimmuno­
T able  3— Thoracoscopic L u n g  B iopsy  in 63 IS o n - im m u n o co m p ro m ised  Patients
No.
Patients
Negative 
Findings in 
Fiberoptic 
Biopsy*
Diagnosis by 
Thoracoscope
Diagnosis by 
Thoracotomy
Duration of 
Drainage, Days 
(Mean and Range) Complications
Fibrosing alveolitis 17 6 17 — 4.1 (2-9) Pneumothorax (1 )
Focal fibrosis 7 3 7 — 5.1 (2-14) Pneumothorax (1 )
Allergic alveolitis 2 2 1 1 3.0 (3-3) —
Histiocytosis X 6 3 5 1 8.5 (4-14) Pleuritis (1) 
Pneumothorax (1 )
Pneumoconiosis 7 4 7 — 4.0 (2-7) Pneumothorax (1 )
Sarcoidosis 7 5 7 — 4.3 (2-9) Wound infection (1)
Lymphangitic carcinoma 5 4 5 — 3.4 (4-4) —
Eosinophilic pneumonia
•
Granulomatous and
3 2 3 — 2.3 (2-3) —
vascular disease 6 3 3 2 4.1 (3-8) —
Hemosiderosis 1 — 1 — 10 —
Tuberculosis 1 — — 1 6 —
Muscular cirrhosis 1 1 1 — 1 —
Total 63 33 57 5 4.5 (1-14) Pneumothorax (4) 
Infection (2)
*Positive findings have only been obtained in patients with sarcoidosis (6), fibrosing alveolitis (2) and malignant lesions (4) 
These 12 patients are not listed in this table, because no thoracoscopy was performed in them.
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compromised patients, a diagnosis was obtained us­
ing the thoracoscopic biopsy technique. No patient 
had a serious complication. In four patients, a pneu­
mothorax persisted over eight days or recurred, and 
in two patients, minor wound infections were seen; 
all of these were handled satisfactorily in a con­
servative way. The mean duration of pleural drain­
age after thoracoscopic lung biopsy was 4.5 days 
(median three days). Pneumothorax persisting over 
a week was mainly seen in patients with low com­
pliances (under 120 ml/cmlHbO).
D is c u s s io n
Thoracoscopy was introduced in 1910 by Jacobae- 
us13 as a way to study the pleura. In the following 
decades, the method was used to destroy pleural 
adhesions which prevented collapse treatment for 
cavitating tuberculosis, in use then. In several Euro­
pean centers, the technique has been used ever 
since to examine collapsed lungs in spontaneous 
pneumothorax and to apply an irritant in the pleural 
cavity to achieve pleurodesis.14 Since 1953, the 
technique has been to obtain biopsy specimens of 
pleural tissue under visual control.15'17 Moreover, 
thoracoscopists were able to provide diagnostic in­
formation in mediastinal disease (tumors, cysts) 
by puncture or biopsy under direct inspection of the 
mediastinum surface, which had been made acces­
sible after an artificial pneumothorax .18 In 1957, 
Heine19 reported a series of patients with diffuse 
interstitial pulmonary disease in whom, after in­
stillation of air in the pleural cavity, a thoracoscope 
was introduced and biopsies of the pulmonary tissue 
were taken under visual control. Independently, 
Kapsenberg20 introduced the method in the Nether­
lands. A new field for thoracoscopy seemed to have 
been opened, but the technique was not widely ac­
cepted, as most pulmonologists preferred open lung 
biopsy for diagnosing diffuse interstitial lung dis­
ease because they feared complications of thoraco­
scopic biopsy. Moreover, its diagnostic value was 
doubted because pathologists claimed to need large 
and deep biopsy specimens for adequate evalua­
tion.
In 1975, one of us (J.D.) was confronted with a 
young man, about two months after renal trans­
plantation, who was in severe respiratory distress, 
with high fever and intense bilateral x-ray film 
shadowing. Anesthesists refused to provide instant 
general anesthesia to this patient and the severe 
hypoxemia (P 02 55 mm Hg under heavy oxygen 
supply by mask, PCO2 28 mm Hg) made bron­
choscopy under tracheal anesthesia extremely un­
attractive. A lung biopsy was taken by thoracoscop­
ic route. Because the procedure was taken very well,
a diagnosis ( Pneumocystis carinii infection) was 
available within hours and recovery was unevent­
ful, we decided to continue practicing thoracoscopy 
in such patients.
After using the procedure in 28 immunocom­
promised patients we remain satisfied. Thoracos­
copy fits in very easily in the daily endoscopic 
activities of our chest department, has been carried 
out even in patients with severe respiratory distress, 
and is taken surprisingly well. The yield of the 
biopsies is very high, and reliable microbiologie and 
morphologic information becomes available at the 
same time.
In a number of cases (Table 2), rather unspecific 
interstitial pneumonitis was found. In such patients, 
however, it was very important to have excluded 
the presence of opportunistic infections, and this 
proved to be so at autopsy in three patients. In 
some, the most likely cause of the interstitial pneu­
monitis seemed to be the previous cytostatic thera­
py; in others, such changes seemed to represent ac­
tivity of the underlying disease, eg, graft vs host 
reaction in bone marrow transplantation, interstitial 
malignant infiltration in angio-immunoblastoma or 
leukemia. Since we have been able to identify spe­
cific opportunistic infections, antimicrobiologic treat­
ment could be very selective and restrictive in these 
patients, thus preventing the appearance of multi- 
resistent microorganisms in the best possible way.
In eight of the 28 immunocompromised patients, 
fiberoptic bronchoscopy had been performed before 
thoracoscopy without providing a diagnosis. When 
comparing fiberoptic bronchoscopy and thoracos­
copy, we hold the view that bronchoscopy rather 
increased respiratory distress and often produced 
inaccurate or no microbiologie information because 
of contamination in the conducting airways where­
as biopsy specimens in all cases were far too small 
for adequate pathologic studies. In contrast to 
bronchoscopy under local anesthesia,20 thoracoscopy 
does not substantially affect the arterial P02,22 bi­
opsy specimens obtained by thoracoscopy are not 
contaminated, and proved to be large enough to 
come to conclusive information in all immunocom­
promised patients and in at least 90 percent of the 
non-immunocompromised patients with diffuse pul­
monary disease.
When comparing thoracoscopy to open chest 
surgery in immunocompromised patients, obviously 
larger specimens can be obtained by the latter 
method and not only superficial lung tissue can be 
studied. In these patients, however, general anesthe­
sia and chest surgery carry definite hazards while 
the results of thoracoscopic biopsy hardly can be 
improved. No disadvantage was experienced in
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obtaining only superficial lung tissue, probably be­
cause there was always diffuse alveolar pathology 
in these patients.
In the nonimmunocompromised group with dif­
fuse pulmonary disease, the situation is different. 
Most of these patients are in much better condition 
than the immunocompromised, and hypoxemia, if 
present, is mild and always easily correctable. In 
these patients, transbronchial lung biopsy during 
bronchoscopy is not a burden as it is in patients 
with respiratory distress, and is considered the first 
approach especially if sarcoidosis is suspected. That 
biopsy during fiberoptic bronchoscopy was success­
ful is reflected by the diagnoses shown in Table 3, 
where sarcoidosis is largely under-represented com­
pared to the type of diagnoses commonly reported 
in series of patients with diffuse pulmonary disease.
In the beginning of this study, the pathologists 
had to become acquainted with the amount of tis­
sue becoming available compared to chest surgery. 
It is relevant to note that in two of five open lung 
biopsies, in retrospect, the thoracoscopic specimen 
had delivered the essential information already. 
Moreover, it turned out that frozen sections could 
provide fast information. In three of six patients 
with granulomatous and vascular disease, the diag­
nosis was not obtained by thoracoscopic biopsy, 
probably because only peripheral vessels could be 
studied. On the other hand, biopsies were taken in 
six patients without roentgenologic lung shadowing 
but showing dyspnea and grossly decreased diffu­
sion tests (D eo ) ,  and in four of them, fibrosing al­
veolitis was diagnosed.
Complications of thoracoscopy and biopsy of 
lung tissue can be expected to arise from the re­
duction of lung volume caused by the artificial 
pneumothorax. In our experience, this risk was 
negligible, provided only a partial collapse of die 
lung was established and patients with hvpercap- 
nia were excluded. A further risk is bleeding from 
intercostal vessels. This risk can be minimized by 
blunt dissection of the subcutaneous tissues and 
the parietal pleura, after which the thoracoscope 
can be introduced smoothly. The chance of a major 
bleeding from biopsy sites in the lung proved to be 
small, because the arteries in the superficial lung 
tissue are tiny and the specimens were torn off and 
not cut. Thrombocytopenia, and other causes of 
bleeding tendency, should be corrected. Arbitrarily 
we chose a bleeding time ( Ivy) of seven minutes 
as a maximum to pursue the procedure, and this 
policy proved to be safe. Infection of the wound 
was a minor complication, and seldom met, even 
in granulopenic patients. In patients with stiff lungs, 
frequently present in diffuse pulmonary disease, re­
expansion took more time than average. Eventually 
all biopsied lungs closed without surgical interven­
tion, except in three patients who died while being 
ventilated. This outcome was related to an unfavor­
able course of the underlying disease.
In our experience, thoracoscopy with transpleural 
lung biopsy is extremely helpful in diagnosing the 
cause of diffuse pulmonary disease in immunocom­
promised patients, causing less of a burden than 
envisaged in open chest surgery and being equally 
effective, without major complications, provided 
strict criteria are observed. It is now our first choice 
approach in such patients, surpassing fiberoptic 
transbronchial biopsy. In nonimmunocompromised 
patients, fiberoptic bronchoscopy is part of our 
routine, but very often transbronchial biopsy speci­
mens are insufficient to establish a solid diagnosis. 
Then we proceed to thoracoscopy and transpleural 
biopsy instead of open chest surgery, which comes 
last, if still needed.
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Comprehensive Review of Infectious Diseases
T he St. Paul-Ramsey Medical C enter will present this course at the Medical Center, 
Septem ber 3 0 -0 c to b e r  2. For information, contact: Continuing Medical Education, 
St. Paul-Ramsey Medical Center, 640 Jackson Street, St. Paul 55101 (612: 221-3992).
Seventh International Conference on Lung Sounds
August 1 is the deadline for abstracts for presentation at this Conference (200 
w ords).  T he  Conference will be held at the M artinez Veterans Administration Medical 
Center, M artinez, California, O ctober 7-8. For information, please contact Raymond 
L. H. M urphy, Jr., M.D., 1153 Centre Street, Boston 02130.
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